Orange Book product · Generic (ANDA)
FUROSEMIDE
FUROSEMIDE
At a glance
Oct 17, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 17, 2022
3 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
FUROSEMIDE
Strength
20MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 216629
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FUROSEMIDE
- 2025LASIX ONYUBrand (NDA)
NDA 217294 · SQ INNOVATION
- 2022FUROSCIXBrand (NDA)
NDA 209988 · SCPHARMACEUTICALS
- 1984FUROSEMIDEBrand (NDA)
NDA 019036 · ABRAXIS PHARM
- 1984FUROSEMIDEBrand (NDA)
NDA 018750 · EPIC PHARMA LLC
- 1984FUROSEMIDEBrand (NDA)
NDA 018902 · FRESENIUS KABI USA
- 1983FUROSEMIDEBrand (NDA)
NDA 018579 · AM REGENT
- 1983FUROSEMIDEBrand (NDA)
NDA 018413 · CHARTWELL RX
- 1982FUROSEMIDEBrand (NDA)
NDA 018507 · ABRAXIS PHARM
- 1982FUROSEMIDEBrand (NDA)
NDA 018670 · WYETH AYERST
- 1982FUROSEMIDEBrand (NDA)
NDA 018667 · HOSPIRA
- 1982FUROSEMIDEBrand (NDA)
NDA 018420 · WARNER CHILCOTT
- —FUROSEMIDEBrand (NDA)
NDA 018267 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
